• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET,ADMINISTRATION,INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET,ADMINISTRATION,INTRAVASCULAR Back to Search Results
Model Number 10016073
Device Problems Fluid/Blood Leak (1250); Material Separation (1562)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/30/2018
Event Type  malfunction  
Manufacturer Narrative
Although requested, device has not been received.A follow up report will be submitted with failure investigation results should the device be received for evaluation.Complaint file: not hispanic/latino, chemotherapy patient.
 
Event Description
The customer reported that the secondary tubing separated and leaked at the bottom of the drip chamber when opening the roller clamp to initiate a mannitol infusion.A primary maintenance fluid of normal saline was attached to the secondary set.The secondary set was newly out of the package when the event occurred.There was no patient or user harm reported.The event occurred in the cancer center.Received a copy of the customer's additional information request letter from fda which states, ¿secondary tubing set was used to prepare a bag of mannitol for administration to patient.The nurse inserted the spike into the bag of mannitol.When she went to open the roller clamp the tubing became detached from the bottom of the drip chamber and the medication went all over the nurse and the floor.The patient was not harmed in any way.The patient was later to receive dose of chemotherapy.If this had been attached to a bag of chemotherapy or other toxic agent there could have been significant risk to staff, patient, and visitors.This is the third occurrence this year with secondary tubing coming undone from the drip chamber in our department"."infuse mannitol as pre medication for chemotherapy".
 
Manufacturer Narrative
The customer¿s complaint of secondary set separated at drip chamber and leaked was confirmed.During visual inspection, it was noted that the pvc tubing was separated from the drip chamber outlet port.Fluid was leaking from the separation.Microscopic inspection observed no solvent applied to either side of the engagement during the manufacturing process.Dimensional analysis of the tubing was within iso-specification.The root cause of the customer¿s report was identified as a manufacturing issue due to no solvent being applied at the junction of the pvc tubing during the manufacturing process.
 
Event Description
It was reported that the secondary tubing separated and leaked at the bottom of the drip chamber when opening the roller clamp to initiate a mannitol infusion.A primary maintenance fluid of normal saline was attached to the secondary set.The secondary set was newly out of the package when the event occurred.There was no patient or user harm reported.The event occurred in the cancer center.Subsequently, a customer medwatch report was received from the fda which states: ¿secondary tubing set was used to prepare a bag of mannitol for administration to patient.The nurse inserted the spike into the bag of mannitol.When she went to open the roller clamp the tubing became detached from the bottom of the drip chamber and the medication went all over the nurse and the floor.The patient was not harmed in any way.The patient was later to receive dose of chemotherapy.If this had been attached to a bag of chemotherapy or other toxic agent there could have been significant risk to staff, patient, and visitors.This is the third occurrence this year with secondary tubing coming undone from the drip chamber in our department." intended procedure: "infuse mannitol as pre medication for chemotherapy".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET,ADMINISTRATION,INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8204628
MDR Text Key131715934
Report Number9616066-2018-02626
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403230110
UDI-Public10885403230110
Combination Product (y/n)N
PMA/PMN Number
K790582
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/05/2021
Device Model Number10016073
Device Catalogue Number10016073
Device Lot Number18095220
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8015,PRI TUBING,8100, TD (B)(6) 2018
Patient Age36 YR
Patient Weight96
-
-